Spacelabs Healthcare Announces Ultraview DM3 Vital Signs Monitor

Issaquah, Wash.-based Spacelabs Healthcare has announced the release of its Ultraview DM3 dual-mode vital signs monitor, which recently received 510(k) clearance from the U.S. Food and Drug Administration, according to a Spacelabs news release.

Advertisement

The Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients, according to the release. It can be used in any patient care environment where basic vital signs monitoring is needed.

In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients. Supplemental patient information, such as pain level, patient position (during NIBP), site check and caregiver ID, can also be specified by the user for inclusion in the patient’s record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system, according to the release. In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance.

Read the Spacelabs’ release on the Ultraview DM3.

Advertisement

Next Up in Uncategorized

  • Nashville, Tenn.-based HCA Healthcare, the largest health system in the country, is seeking finance chiefs at six of its hospitals. …

Advertisement

Comments are closed.